All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

110

Reset

110 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CagrilintidePhase 320 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • RetatrutideLY3437943Phase 316 trials

    Eli Lilly · Obesity, Overweight, Type 2 Diabetes

  • Maridebart cafraglutideAMG 133Phase 314 trials

    Amgen · Obesity, Overweight, Obstructive Sleep Apnea

  • EloralintideLY3841136Phase 313 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • HRS9531Phase 313 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Type 2 Diabetes, Chronic Management of Body Weight, Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  • NNC0487-0111Phase 312 trials

    Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • BofanglutideGZR18, BofanglutidaPhase 311 trials

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM), Obstructive Sleep Apnea (OSA), Obesity/Overweight in Adult

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • UBT251Phase 310 trials

    The United Bio-Technology (Hengqin) Co., Ltd. · Obesity, Obesity &Amp; Overweight, Diabetes Mellitus, Type 2

  • ElecoglipronPhase 39 trials

    AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight

  • LenbelintideAZD6234Phase 39 trials

    AstraZeneca · Obesity or Overweight, Obesity, Overweight

  • Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • ZenagamtidePhase 39 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • ObicetrapibPhase 37 trials

    NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption

  • AleniglipronPhase 36 trials

    Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Obesity, Overweight, Chronic Weight Management

  • CagriSemaCagrilintide B and Semaglutide IPhase 36 trials

    Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Hypertension

  • MWN109 1Phase 36 trials

    Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)

  • MWN109 2Phase 36 trials

    Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)

  • ASC30 A1ASC30Phase 35 trials

    Ascletis Pharma (China) Co., Limited · Chronic Weight Management, Obesity, Overweight

  • BGM0504Phase 35 trials

    BrightGene Bio-Medical Technology Co., Ltd. · Type 2 Diabetes (T2DM), Overweight or Obese Participants Without Diabetes, Obesity

  • HDM1005Phase 35 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obstructive Sleep Apnea (OSA) and Obesity, Obesity, Type 2 Diabetes

  • MazdutideLY3305677Phase 35 trials

    Eli Lilly · Type 2 Diabetes, Obesity, Overweight

  • MWN109 3Phase 35 trials

    Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)

  • RAY1225Phase 35 trials

    Guangdong Raynovent Biotech Co., Ltd · Obesity, T2DM, T2DM (Type 2 Diabetes Mellitus)

  • SHR-3167Phase 35 trials

    Jiangsu HengRui Medicine Co., Ltd. · Diabetes Mellitus, Type 2, Type 2 Diabetes, Type 2 Diabetes Mellitus

  • VCT220CX11Phase 35 trials

    Vincentage Pharma Co., Ltd · Obesity, Type 2 Diabetes Mellitus (DM), Hypertension

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • HDM1002Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight and Obesity

  • HDM1005 1Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight

  • HDM1005 2Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight

  • HTD1801Berberine UrsodeoxycholatePhase 34 trials

    Shenzhen HighTide Biopharmaceutical Ltd. · T2DM (Type 2 Diabetes Mellitus), Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes

  • DA-302168SPhase 33 trials

    Chendu DIAO Pharmaceutical Group CO., LTD. · Overweight and Obesity, Type 2 Diabetes Mellitus

  • SurvodutideBI 456906Phase 33 trials

    Boehringer Ingelheim · Obesity, Type 2 Diabetes, Overweight

  • TG103Phase 33 trials

    CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Type 2 Diabetes Mellitus, Overweight or Obesity

  • BGM0504 AdministeredPhase 32 trials

    BrightGene Bio-Medical Technology Co., Ltd. · Type 2 Diabetes Mellitus (T2DM)

  • ClazakizumabLY5724886, CSL300Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity

  • DWP16001Phase 32 trials

    Daewoong Pharmaceutical Co. LTD. · Type 2 Diabetic Nephropathy, T2DM (Type 2 Diabetes Mellitus)

  • Exendin-4 Fc fusion proteinJY09Phase 32 trials

    Beijing Dongfang Biotech Co., Ltd. · Type2 Diabetes Mellitus, Type 2 Diabetes Mellitus

  • ezetimibe FDCPhase 32 trials

    NewAmsterdam Pharma · Lipidemia, Coronary Artery Disease, Plaque, Atherosclerotic

  • HM11260CPhase 32 trials

    Hanmi Pharmaceutical Company Limited · Type 2 Diabetes, Obesity

  • HR17031Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Adult Patients With Type 2 Diabetes, Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs

  • IN-B00009Phase 32 trials

    HK inno.N Corporation · Obesity &Amp; Overweight, Diabetes (DM), Diabetes Mellitus Type 2

  • Insuline glargine U100reduced, titratedPhase 32 trials

    Ascentage Pharma Group Inc. · Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy, Diabetes Mellitus, Type 2

  • matched to semaglutidePhase 32 trials

    Novo Nordisk · Overweight, Obesity, Diabetes Mellitus, Type 2

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • THDB0206Phase 32 trials

    Tonghua Dongbao Pharmaceutical Co.,Ltd · Type 2 Diabetes, Type 1 Diabetes

  • AD-233APhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233BPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233CPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

Page 1 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.